Search Videos and More


Improving Transcatheter Aortic Valve Replacement (TAVR) for COVID-19 and Beyond News

Improving Transcatheter Aortic Valve Replacement (TAVR) for COVID-19 and Beyond

Learn more about the ways the COVID-19 pandemic led to new patient-safety driven approaches for the Transcatheter Aortic Valve Replacement (TAVR)—an important development for high-risk patients with aortic stenosis. From limited hospital exposure to even shorter recovery, AMITA Health Cardiovascular Institute is applying these changes to the post-COVID landscape.
Improving Heart Failure Patient Longevity: Left Ventricular Assist Device (LVAD) Video

Improving Heart Failure Patient Longevity: Left Ventricular Assist Device (LVAD)

Drs. Ashish Haryani and William E. Stansfield discuss LVAD implanted into a 60-year-old male with severe end-stage heart failure and history of cancer and stroke.
Comprehensive Leading-edge Care in Vascular Surgery Video

Comprehensive Leading-edge Care in Vascular Surgery

Atif Baqai, MD, FACS, RPVI, Division Chief of Vascular Surgery at AMITA Health and Tejas Shah, MD,FACS, RPVI, Vascular Surgeon at AMITA Health, present a case study of a surgical repair of a 14-cm abdominal aortic aneurysm with aorto-caval fistula.
The Watchman™ Procedure: Leading-Edge Care for Atrial Fibrillation News

The Watchman™ Procedure: Leading-Edge Care for Atrial Fibrillation

The AMITA Health Heart & Vascular Institute is one of only two institutions in the Chicago suburbs that offers the Watchman™ procedure to reduce risk of stroke in patients with AFib.
Putting Innovation into Practice: Expanded Options for Aortic Stenosis News

Putting Innovation into Practice: Expanded Options for Aortic Stenosis

At the AMITA Health Heart & Vascular Institute, a multidisciplinary team of specialists provides leading-edge treatment options for heart valve replacement in patients with aortic stenosis.
Meeting the Needs of Patients with Atrial Fibrillation News

Meeting the Needs of Patients with Atrial Fibrillation

Atrial fibrillation is not a benign disease and should be evaluated and treated as soon as possible after diagnosis.
Now Offering Innovative Approaches to Mitral Valve Repair News

Now Offering Innovative Approaches to Mitral Valve Repair

For patients with severe mitral regurgitation, evidence of degenerative mitral valve disease on transesophageal echocardiography (TEE), and for those patients who are at high risk of surgical complications (based on the STS scoring system – see link), the Heart Valve Program at the AMITA Health Heart & Vascular Institute now offers an FDA-approved, minimally invasive procedure for mitral valve repair using the MitraClip® device.